Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana

FEMS Microbiology Letters

Volumn 215, Issue 2, 2002, Pages 249-253

  Mills Robertson, Felix ^a,b   Addy, Marian E ^b   Mensah, Patience ^c   Crupper, Scott S ^d  

^a Centre for Scientific Research Into Plant Medicine Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c University of Ghana   (Ghana)

^d EMPORIA STATE UNIVERSITY   (United States)

Author keywords

IncHI; Incompatibility group; Multiple antibiotic resistance; Salmonella typhi

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; COTRIMOXAZOLE; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GHANA; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SALMONELLA TYPHI; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; CONJUGATION, GENETIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE TRANSFER, HORIZONTAL; GHANA; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SALMONELLA TYPHI; TRANSFORMATION, BACTERIAL; TYPHOID FEVER;

SALMONELLA; SALMONELLA TYPHI;

EID: 0037044464     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)00967-9     Document Type: Article

References (32)

1. Thong K.L., Cheong M.Y., Puthucheary S., Koh C.L., Pang T. Epidemiologic analysis of sporadic Salmonella typhi isolates and those from outbreaks by pulsed-field gel electrophoresis. J. Clin. Microbiol. 32:1994;1135-1141.
2. DuPont H.L. Quinolones in Salmonella typhi infection. Drugs. 45:1993;119-124.
3. Islam A., Butler T., Kabir I., Alam N.H. Treatment of typhoid fever with ceftriaxone for 5 days of chloramphenicol for 14 days: a randomized clinical trial. Antimicrob. Agents Chemother. 37:1993;1572-1575.
4. Datta N., Richards H., Datta C. Salmonella typhi in-vivo acquires resistance to both chloramphenicol and cotrimoxazole. Lancet. i:1981;1181-1183.
5. Olarte J., Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob. Agents Chemother. 4:1973;597-601.
6. Ling J., Chau P.Y. Plasmid mediating resistance to chloramphenicol, trimethoprim, and ampicillin in Salmonella typhi in the Southeast Asia region. J. Infect. Dis. 149:1984;652.
7. Rowe, B., Ward, L.R. and Threlfall, E.J. (1990) Spread of multiresistant Salmonella typhi. Lancet 337, 1065. (Letter).
8. Asperilla M.O., Smego R.A. Jr., Scott L.K. Quinolone antibiotics in the treatment of Salmonella infections. Rev. Infect. Dis. 12:1990;873-889.
9. Eykyn S.J., Williams H. Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet. ii:1987;1407-1408.
10. Chitnis V., Chitnis D., Verma S., Hemvani N. Multidrug-resistant Salmonella typhi in India. Lancet. 354:1999;514-515.
11. Kapil A., Sood S., Dash N.R., Das B.K., Seth P. Ciprofloxacin in typhoid fever. Lancet. 354:1999;164.
12. Rowe B., Ward L.R., Threlfall E.J. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet. 346:1995;1302.
13. Anderson E.S., Smith H.R. Chloramphenicol resistance in the typhoid bacillus. Br. Med. J. 3:1972;329-331.
14. Awotedu A.A., Oyelese A.O., Onadeko B.O. Clinical trial of sulbactam/ampicillin in the treatment of typhoid fever, and in-vitro sensitivity of isolates to sulbactam/ampicillin and chloramphenicol. West Afr. J. Med. 11:1992;274-277.
15. Ibe S.N., Wariso B.A. Drug susceptibility profile of Salmonella typhi blood isolates in Port Harcourt, Nigeria. West Afr. J. Med. 15:1996;219-222.
16. Farmer, J.J. III (1999) Enterobacteriaceae: introduction and identification. In: Manual of Clinical Microbiology, 7th edn. (Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C. and Yolken, R.H., Eds.), pp. 442-458. ASM Press, Washington, DC.
17. National Committee for Clinical Laboratory Standards (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. National Committee for Clinical Laboratory Standards (1998) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
19. National Committee for Clinical Laboratory Standards (1998) Development of in vitro susceptibility testing criteria and quality control parameters. NCCLS document M23-T2. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. National Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing. Suppl. M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA.
21. Sambrook, J., Fritsch, E. and Maniatis, T. (1987) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Gabant P., Newnham P., Taylor D., Couturier M. Isolation and location on the R27 map of two replicons and an incompatibility determinant specific for IncHI1 plasmids. J. Bacteriol. 175:1993;7697-7701.
23. Shanahan P.M.A., Jesudason M.V., Thomson C.J., Amyes S.G.B. Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. J. Clin. Microbiol. 36:1998;1595-1600.
24. Mourad A.S., Metwally M., Nour El Deen A., Threlfall E.J., Rowe B., Mapes T., Hedstrom R., Bourgeois A.L., Murphy J.R. Multiple-drug-resistant Salmonella typhi. Clin. Infect. Dis. 17:1993;135-136.
25. Wallace M., Yousif A.A. Spread of multiresistant Salmonella typhi. Lancet. 336:1993;1065-1066.
26. Gulati S., Marwaha R.K., Singhi S., Ayyagari A., Kumar L. Third generation cephalosporins in multi-drug resistant typhoid fever. Indian Pediatr. 29:1992;513-516.
27. Mathai D., Kudwa G.C., Keystone J.S., Kozarsky P.E., Jesudason M.V., Lalitha M.K., Kaur A., Thomas M., John J., Pulimood B.M. Short course of ciprofloxacin in enteric fever. J. Assoc. Physicians India. 41:1993;7428-7430.
28. Mirza S.H., Hart C.A. Plasmid encoded multi-drug resistance in Salmonella typhi from Pakistan. Ann. Trop. Med. Parasitol. 87:1993;373-377.
29. Threlfall E.J., Ward L.R., Rowe B., Raghupathi S., Chandrasekaran V., Vandepitte J., Lemmens P. Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;990-993.
30. Goldstein F.W., Chumpitaz J.C., Guevara J.M. Plasmid mediated resistance to multiple antibiotics in S. typhi. J. Infect. 153:1986;261-266.
31. Karmaker S., Biswas D., Shaikh N.M., Chatterjee S.K., Kataria V.K., Kumar R. Role of a large plasmid of Salmonella typhi encoding multiple dug resistance. J. Med. Microbiol. 34:1991;149-151.
32. World Health Organization. http://www.who.int/home-page/.